CRESEMBA
Active substance: isavuconazonium
CAPSULE · ISAVUCONAZONIUM SULFATE 100 mg/1
United StatesActive
Marketing holder: Astellas Pharma US, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ISAVUCONAZONIUM SULFATE · 100 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12099-ac1d-77c2-84ad-1c00647b30c8,01a12099-ad85-7d45-b066-f431348340f7,01a1209b-f3a9-75b3-b316-49dd34a30b27;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0469-0520
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0469-0520 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0469-0520 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0469-0520 · Verified 2026-10-09 · open in source